Účtovná hodnota akcie spoločnosti AMAG Pharmaceuticals
Aká je hodnota metriky Účtovná hodnota akcie spoločnosti AMAG Pharmaceuticals?
Hodnota metriky Účtovná hodnota akcie spoločnosti AMAG Pharmaceuticals, Inc. je 8.24
Aká je definícia metriky Účtovná hodnota akcie?
Účtovná hodnota akcie (Book/Share) sa rovná majetku spoločnosti mínus záväzky spoločnosti podelené počtom vydaných akcií.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Účtovná hodnota akcie spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou AMAG Pharmaceuticals
Čomu sa venuje spoločnosť AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Firmy s metrikou účtovná hodnota akcie podobnou spoločnosti AMAG Pharmaceuticals
- Hodnota metriky Účtovná hodnota akcie spoločnosti Powerleader Science & Technology je 8.22
- Hodnota metriky Účtovná hodnota akcie spoločnosti BlackRock MuniVest Fund, Inc je 8.22
- Hodnota metriky Účtovná hodnota akcie spoločnosti Tootsie Roll Industries je 8.23
- Hodnota metriky Účtovná hodnota akcie spoločnosti Howmet Aerospace je 8.23
- Hodnota metriky Účtovná hodnota akcie spoločnosti Prudential plc je 8.24
- Hodnota metriky Účtovná hodnota akcie spoločnosti KE je 8.24
- Hodnota metriky Účtovná hodnota akcie spoločnosti AMAG Pharmaceuticals je 8.24
- Hodnota metriky Účtovná hodnota akcie spoločnosti Li Auto je 8.24
- Hodnota metriky Účtovná hodnota akcie spoločnosti SUEZ SA je 8.24
- Hodnota metriky Účtovná hodnota akcie spoločnosti Yuexiu Transport Infrastructure je 8.25
- Hodnota metriky Účtovná hodnota akcie spoločnosti Weiye je 8.25
- Hodnota metriky Účtovná hodnota akcie spoločnosti Tata Sponge Iron je 8.25
- Hodnota metriky Účtovná hodnota akcie spoločnosti Mayne Pharma je 8.25